Evidence map›Paper›PMID 41466327›Full record

ArticleCancer imaging : the official publication of the International Cancer Imaging Society2025

CT-based AI score associates with perioperative outcomes in nephron-sparing surgery for renal cell carcinoma.

Lin Shengfa, Su Liqing, Chen Shu, Chen Huijian, Lin Yuying, Lin Zijie, Xia Yinfeng, Li Qianwen, Fang Zhuting, Ma Mingping and 1 more

Abstract read
In one paragraph

Article in Cancer imaging : the official publication of the International Cancer Imaging Society, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Lin Shengfa *Department of Radiology, Shengli Clinical Medical College of Fujian Medical University, Fujian Provincial Hospital, Fuzhou University Affiliated Provincial Hospital, No. 134, Dong Street, Gulou District, Fuzhou, Fujian, 350001, China.
Su Liqing *Department of Radiology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, Fujian, 350011, China.
Chen Shu *College of Physics and Information Engineering, Fuzhou University, Fuzhou, Fujian, 350001, China.
Chen HuijianDepartment of Radiology, Shengli Clinical Medical College of Fujian Medical University, Fujian Provincial Hospital, Fuzhou University Affiliated Provincial Hospital, No. 134, Dong Street, Gulou District, Fuzhou, Fujian, 350001, China.
Lin YuyingDepartment of Radiology, Shengli Clinical Medical College of Fujian Medical University, Fujian Provincial Hospital, Fuzhou University Affiliated Provincial Hospital, No. 134, Dong Street, Gulou District, Fuzhou, Fujian, 350001, China.
Lin ZijieDepartment of Radiology, Shengli Clinical Medical College of Fujian Medical University, Fujian Provincial Hospital, Fuzhou University Affiliated Provincial Hospital, No. 134, Dong Street, Gulou District, Fuzhou, Fujian, 350001, China.
Xia YinfengDepartment of Radiology, Shengli Clinical Medical College of Fujian Medical University, Fujian Provincial Hospital, Fuzhou University Affiliated Provincial Hospital, No. 134, Dong Street, Gulou District, Fuzhou, Fujian, 350001, China.
Li QianwenInformation Management Center, Provincial Key Laboratory of Medical Big Data Engineering, Fuzhou University Affiliated Provincial Hospital, Fuzhou, Fujian, 350001, China.
Fang Zhuting *Department of Oncology and Vascular Intervention, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, No. 420, Fuma Road, Jinan District, Fuzhou, Fujian, 350011, China. ztfang@fjzlhospital.com.
Ma MingpingDepartment of Radiology, Shengli Clinical Medical College of Fujian Medical University, Fujian Provincial Hospital, Fuzhou University Affiliated Provincial Hospital, No. 134, Dong Street, Gulou District, Fuzhou, Fujian, 350001, China. f007820@163.com.
Hu MinxiongDepartment of Urology, Shengli Clinical Medical College of Fujian Medical University, Fuzhou University Affiliated Provincial Hospital, No. 134, Dong Street, Gulou District, Fuzhou, Fujian, 350001, China. 371007485@qq.com.

Funding

the Fujian Province Natural Science Fund Project 2024J011105the Guiding Project of Fujian Provincial Department of Science and Technology 2022Y0052the Joint Funds for the Innovation of Science and Technology, Fujian Province No. 2023Y9320the Major Project of Fujian Provincial Health 2024ZD01004the National Key R&D Program of China 2023YFC2413500the Startup Fund for Scientific Research and Fujian Medical University 2021QH1283the Startup Fund for Scientific Research, Fujian Medical University 2023QH1174
6 · The paper itself

Abstract

backgroundTo develop and validate a CT-based artificial intelligence (AI) score model integrating the R.E.N.A.L. nephrometry and contact surface area (CSA) for efficient, accurate prediction of perioperative outcomes in renal cell carcinoma (RCC) patients undergoing nephron-sparing surgery (NSS), addressing the subjectivity and inefficiency of manual score.

methodsRetrospectively collected data from two NSS cohorts (n1 = 500, n2 = 50): 90% of cases in Cohort n1 (450 cases) were randomly assigned to the training set (315 cases), validation set (45 cases), and test set (90 cases) at a ratio of 7:1:2, which were used to develop and validate the automated kidney/tumor segmentation models, as well as to derive the AI-calculated R.E.N.A.L. score (with the "A" parameter excluded) and AI-calculated CSA score; the remaining 10% of cases in Cohort n1 (50 cases) were combined with all 50 cases in Cohort n2 to form a mixed validation set (100 cases), which was used for risk stratification prediction of NSS perioperative outcomes via AI scores. Manual image annotation/scoring was conducted by experienced radiologists and urologists. Interrater consistency was evaluated via weighted kappa coefficients; risk stratification was performed via Kruskal-Wallis tests and Mann-Whitney U tests.

resultsA total of 550 patients were included in this study (median age, 56 [IQR: 46-66] years; 341 males). The segmentation model exhibited excellent performance: Dice similarity coefficient (DSC) was 0.95 for kidneys and 0.80 for tumors; normalized surface distance (NSD) was 0.923 ± 0.082 and 0.892 ± 0.096, respectively; 95th percentile Hausdorff distance (HD95) was 9.78 ± 0.63 mm and 12.65 ± 0.84 mm, respectively. The R, E, N, L, R.E.N.A.L., and CSA score models had good consistency compared with the manual score, and the kappa coefficients were 0.82, 0.49, 0.63, 0.60, 0.65, and 0.69, respectively (all P < 0.01). Risk stratification by AI score significantly predicted warm ischemia time, surgical duration, intraoperative blood loss, serum creatinine changes, pathological T stage, and nuclear grade (all P < 0.05).

conclusionsThis study successfully developed a CT-based automated kidney/tumor segmentation model, and on this basis constructed the AI-R.E.N.A.L. and AI-CSA scoring models, providing an efficient and objective preoperative risk assessment tool for the perioperative outcomes of NSS.

Indexed as

Artificial IntelligenceCarcinoma, Renal CellKidney NeoplasmsNephrectomyOrgan Sparing TreatmentsTomography, X-Ray ComputedAgedFemaleHumansMaleMiddle AgedNephronsRetrospective StudiesTreatment OutcomeArtificial intelligenceComputed tomographyContact surface areaNephron-sparing surgeryRenal cell carcinomaR.E.N.A.L. nephrometry

Identifiers

PMID41466327
PMCPMC12751408

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.